A Relative Strength Rating upgrade for Chesapeake Utilities shows improving technical performance. Will it continue?

Abu Dhabi, UAE: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a ...

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

Developing a vaccination program for infectious bursal disease virus (IBDV) challenges should consider the severity and ...

Alcohol can worsen Crohn’s disease symptoms, but the impact varies from person to person. It may depend on what and how much ...

Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, ...

Veterans Day falls on Monday, Nov. 11 2024 as the nation pauses to honor our country’s heroes. Veterans Day is a federal holiday and many parts of the government, both federal and local will be closed ...

A Relative Strength Rating upgrade for Assured Guaranty shows improving technical performance. Will it continue?

Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.